Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19...
from NDTV News - Special https://ift.tt/3vLxZQ6
Subscribe to:
Post Comments (Atom)
-
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3GZROJ...
-
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2F7raU...
-
Fitch Ratings on Thursday revised India's outlook to 'negative' from 'stable', stating that the coronavirus pandemic has...
No comments:
Post a Comment